Filter
64
Text search:
antimalarial
Pharmaceuticals
Featured
Recommendations
4
New Publications
20
Language
Document type
No document type
33
Guidelines
11
Studies & Reports
9
Manuals
4
Strategic & Response Plan
4
Training Material
3
Countries / Regions
Uganda
5
Nigeria
4
Kenya
4
Tanzania
4
Liberia
3
Ethiopia
3
Ghana
3
Zimbabwe
3
Malawi
3
Philippines
2
India
2
Cambodia
2
East and Southern Africa
2
South–East Asia Region
2
Latin America and the Carribbean
2
Global
2
Sierra Leone
1
Congo, Democratic Republic of
1
Haiti
1
Nepal
1
Pakistan
1
Lebanon
1
Zambia
1
Thailand
1
Rwanda
1
Bangladesh
1
Mozambique
1
Dominican Republic
1
Honduras
1
El Salvador
1
Libya
1
Guatemala
1
Nicaragua
1
West and Central Africa
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Western and Central Europe
1
Africa
1
Belize
1
Costa Rica
1
Panama
1
Authors & Publishers
Publication Years
Category
Countries
40
Clinical Guidelines
3
Women & Child Health
3
Public Health
2
Key Resources
2
Pharmacy & Technologies
2
Toolboxes
Pharmacy
12
Malaria
6
AMR
4
Rapid Response
2
2.0 Rapid Response
2
Ebola & Marburg
1
Health Financing Toolbox
1
Master of Science in Pharmaceutical Management Dissertation
The prevalence, availability, and use of antimalarial medicines (AMLs) were studied in six Cambodian provinces along the Thai-Cambodian border. The study was divided into two parts: the first looked at the quality of AMLs available in Pursat, Pailin
...
Survey of the Quality of Selected Antimalarial Medicines Circulating in Six Countries of Sub-Saharan Africa
recommended
The survey aimed at evaluating the quality of selected antimalarials in six countries of sub-Saharan Africa (Cameroon, Ethiopia, Ghana, Kenya, Nigeria and the United Republic of Tanzania). These countries have been supported by WHO to strengthen their regulatory controls o
...
Submitted to the US Agency for International Development by the
Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program.
This manual provides a framework to identify problems and design interventions to improve access to and us
...
The pharmaceutical sector of any nation is responsible for providing society with quality medicines and other pharmaceutical services. According to the World Health Organization (WHO), Pharmaceuticals may constitute as much as 40% of the national he
...
A role for nuclear techniques
Antimicrobials play a critical role in the treatment of human and animal (aquatic and terrestrial) diseases, which has led to their widespread application and use. Antimicrobial resistance (AMR) is the ability of microorganisms to stop an antibiotic, such as an antimic
...
In the mid-1980s, recognizing the limitations of traditional training and that the knowledge and skills acquired are not necessarily applied back in the workplace, MSH developed the Monitoring‐Training-Planning (MTP) approach to assist the Ecuadorian Ministry of Health to implement its Child Survi
...
This field study to measure access to and use of medicines was undertaken in GHANA in May-June 2008. The study assessed information on the socio-economic level of households, and access to and use of medicines for acute and chronic conditions as well as opinions and perceptio
...
WHO Model Formulary
recommended
For each medicine the Formulary provides information on use, dosage, adverse effects, contraindications and warnings, supplemented by guidance on selecting the right medicine for a range of conditions
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while focusing on counterfeit medicines and medical devices in developing countries, will present information
...
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
Accessed July 2014.
6th edition, 2010. | Published in collaboration with World Health Organisation and Clinton Health Access Initiative.
Early-warning indicators to prevent stock-outs and overstocking of antiretroviral, antituberculosis and antimalaria medicines.
